Prescriber's Corner
Crizotinib: A Breakthrough for Targeted Therapies in Lung Cancer
Jennifer Kwon, PharmD, and ALISON MEAGHER, PharmD
From Roswell Park Cancer Institute, Buffalo, New York
The authors have no conflicts of interest to disclose.
Correspondence to: Jennifer Kwon, PharmD, Roswell Park Cancer Institute, Pharmacy Services, Elm and Carlton Streets, Buffalo, NY 14263. E-mail: jennifer.kwon@roswellpark.org
J Adv Pract Oncol 2012;3:267–272 |
DOI: 10.6004/jadpro.2012.3.4.8 |
© 2012 Harborside Press®
For access to the full length article, please
sign in.